PENBRAYA
STN: 125770
Proper Name: Meningococcal Groups A, B, C, W, and Y Vaccine
Tradename: PENBRAYA
Manufacturer: Pfizer Ireland Pharmaceuticals
Indication:
- PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. PENBRAYA is approved for use in individuals 10 through 25 years of age.
Product Information
- Package Insert - PENBRAYA
- Demographic Subgroup Information - Meningococcal Groups A, B, C, W, and Y Vaccine (PENBRAYA)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.